Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses And Other Current Liabilities (Tables)

v3.19.1
Accrued Expenses And Other Current Liabilities (Tables)
3 Months Ended
Mar. 31, 2019
Accrued Liabilities and Other Liabilities [Abstract]  
Schedule of accrued expenses and other current liabilities
Accrued expenses and other current liabilities as of March 31, 2019 and December 31, 2018 consisted of the following:
 
 
As of
 
 
March 31, 2019
 
December 31, 2018
Sales returns and allowances
 
$
4,249,977

 
$
3,972,510

Medicaid rebates
 
2,758,384

 
2,237,269

Minimum sales commitments, royalties payable, and purchase obligations
 
10,808,083

 
9,662,901

Compensation and benefits
 
1,679,572

 
1,953,065

Research and development expenses
 
1,123,051

 
278,132

Sales and marketing
 
938,437

 
1,112,378

General and administrative
 
187,465

 
235,721

Other
 
70,128

 
279,397

Total accrued expenses and other current liabilities
 
$
21,815,097

 
$
19,731,373